| The strengths and limitations of using biolayer interferometry to monitor equilibrium titrations of biomolecules CJ Weeramange, MS Fairlamb, D Singh, AW Fenton, L Swint‐Kruse Protein Science, 2020 | 30 | 2020 |
| Homolog comparisons further reconcile in vitro and in vivo correlations of protein activities by revealing over‐looked physiological factors S Tungtur, KM Schwingen, JJ Riepe, CJ Weeramange, L Swint‐Kruse Protein Science 28 (10), 1806-1818, 2019 | 15 | 2019 |
| Protein-protein interactions with fructose-1-kinase alter function of the central Escherichia coli transcription regulator, Cra D Singh, MS Fairlamb, KS Harrison, C Weeramange, S Meinhardt, ... BioRxiv, 201277, 2017 | 13 | 2017 |
| Total synthesis of reniochalistatin E A Fatino, G Baca, C Weeramange, RJ Rafferty Journal of natural products 80 (12), 3234-3240, 2017 | 8 | 2017 |
| The winding road of the uvaretin class of natural products: from total synthesis to bioactive agent discovery J Dallman, A Lansakara, T Nguyen, C Weeramange, W Hulangamuwa, ... MedChemComm 10 (8), 1420-1431, 2019 | 6 | 2019 |
| Inhibition of UDP-glucose dehydrogenase by 6-thiopurine and its oxidative metabolites: Possible mechanism for its interaction within the bilirubin excretion pathway and 6TP … CJ Weeramange, CM Binns, C Chen, RJ Rafferty Journal of Pharmaceutical and Biomedical Analysis 151, 106-115, 2018 | 5 | 2018 |
| Efforts in redesigning the antileukemic drug 6-thiopurine: decreasing toxic side effects while maintaining efficacy AXT Hernandez, CJ Weeramange, P Desman, A Fatino, O Haney, ... MedChemComm 10 (1), 169-179, 2019 | 4 | 2019 |
| New methods to assess 6-thiopurine toxicity and expanding its therapeutic application to pancreatic cancer via small molecule potentiators C Weeramange, A Lansakara, J Dallman, T Nguyen, W Hulangamuwa, ... MedChemComm 10 (5), 717-725, 2019 | 2 | 2019 |
| Construction and Biological Evaluation of Small Libraries Based on the Intermediates within the Total Synthesis of Uvaretin S Perera, A Fernando, J Dallman, C Weeramange, A Lansakara, ... ChemMedChem 16 (10), 1631-1639, 2021 | 1 | 2021 |
| Reconciling in vitro and in vivo activities of engineered, LacI-based repressor proteins: Contributions of DNA looping and operator sequence variation S Tungtur, KM Schwingen, JJ Riepe, CJ Weeramange, L Swint-Kruse bioRxiv, 477893, 2018 | 1 | 2018 |
| Fructose-1-kinase has pleiotropic roles in Escherichia coli C Weeramange, C Menjivar, PT O’Neil, S El Qaidi, KS Harrison, ... Journal of Biological Chemistry 300 (6), 2024 | | 2024 |
| Using of bio-layer interferometry to quantify protein-DNA interactions C Weeramange, M Fairlamb, L Swint-Kruse ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019 | | 2019 |
| 6-Thiopurine: Targeting UDP-glucose dehydrogenase and its efficacy effects C Weeramange, R Rafferty ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 255, 2018 | | 2018 |
| 6-Thiopurine: Understanding the mode of toxicity through exploring UDP-glucose dehydrogenase activity C Weeramange, R Rafferty ACS Midwest Regional Meeting 2016, Manhattan, KS, 2016 | | 2016 |
| HPLC method development assessing the possibly trigger of 6-thiopurine toxicity C Weeramange, R Rafferty ACS Midwest Regional Meeting 2015, St. Joseph, MO, 2015 | | 2015 |
| Reniochalistatin E: A Potentiating Agent and a Potential Novel Drug Delivery Platform KR Wildeman, M Barnett, A Fatino, C Weeramange, R Rafferty Available at SSRN 5041490, 0 | | |
Liskin Swint-KruseThe University of Kansas Medical Center在 kumc.edu 的电子邮件经过验证
